|
Volumn 11, Issue 8, 2010, Pages
|
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZENESULFONIC ACID DERIVATIVE;
INDOLE DERIVATIVE;
MITOGEN ACTIVATED PROTEIN KINASE;
PROTEIN KINASE B;
PROTEIN KINASE INHIBITOR;
PROTEIN RET;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
RET PROTEIN, HUMAN;
SORAFENIB;
SUNITINIB;
TUMOR PROTEIN;
ADENOCARCINOMA;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
GENE DOSAGE;
GENE EXPRESSION REGULATION;
GENETIC SELECTION;
GENETICS;
HIGH THROUGHPUT NUCLEOTIDE SEQUENCING;
HUMAN;
LUNG TUMOR;
METABOLISM;
METASTASIS;
MUTATION;
PATHOLOGY;
TONGUE TUMOR;
TUMOR GENE;
ADENOCARCINOMA;
BENZENESULFONATES;
GENE DOSAGE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENES, NEOPLASM;
HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING;
HUMANS;
INDOLES;
LUNG NEOPLASMS;
MITOGEN-ACTIVATED PROTEIN KINASES;
MUTATION;
NEOPLASM PROTEINS;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS C-AKT;
PROTO-ONCOGENE PROTEINS C-RET;
PYRIDINES;
PYRROLES;
SELECTION, GENETIC;
TONGUE NEOPLASMS;
|
EID: 77955293476
PISSN: None
EISSN: 14656914
Source Type: Journal
DOI: 10.1186/gb-2010-11-8-r82 Document Type: Article |
Times cited : (151)
|
References (0)
|